secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001161697-25-000168
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical reports record Q1 revenue of $9.6M, up 18% YoY; raises FY2025 guidance
--------------------------------------------------------------------------------

- Core revenue (Domestic + International) grew 21% YoY to $9.4M; International up 35.6%.
- Gross margin improved 50 bps to 62.8%; gross profit $6.0M, up 19%.
- Net loss narrowed; adjusted EBITDA improved to ($0.2M) from ($0.9M) prior year.
- FY2025 revenue guidance raised to $38.5-39.5M from $38-39M; gross margin guidance reiterated at 61-63%.
- Plans to submit two drugs for FDA 510(k) clearance with Freedom Infusion System by year-end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169725000168/0001161697-25-000168-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169725000168/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-25-000168

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer